Condition: Systematic Lupus Erythematosus · Cutaneous Lupus Erythematosus · Sponsor: EMD Serono Research & Development Institute, Inc.
The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 weeks. Treatment Duration: 24 weeks. Visit Frequency: every 4 weeks, with the exception of the Week 2 televisit. Study Intervention Name: Enpatoran, Placebo. Intervention Form: Film-coated tablet.
This description comes directly from the study's public registry record.
US Medical Information · 888-275-7376 · eMediUSA@emdserono.com
Communication Center · +49 6151 72 5200 · service@emdgroup.com
Always discuss trial participation with your own doctor first.
| Inland Rheumatology Clinical Trials, Inc. | Upland, California, United States | Recruiting |
| Omega Research Debary, LLC | DeBary, Florida, United States | Recruiting |
| South Florida Rheumatology | Hollywood, Florida, United States | Recruiting |
| GTL Medical And Research Group | Miami, Florida, United States | Recruiting |
| Bolanos Clinical Research | Pembroke Pines, Florida, United States | Recruiting |
| Vantage Clinical Trials | Tampa, Florida, United States | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis, Indiana, United States | Recruiting |
| Accurate Clinical Research Inc. - Lake Charles | Lake Charles, Louisiana, United States | Recruiting |
| Oakland Hills Dermatology | Auburn Hills, Michigan, United States | Recruiting |
| Arthritis and Osteoporosis Consultants of the Carolinas II, LLC | Charlotte, North Carolina, United States | Recruiting |
| North Texas Center for Clinical Research | Frisco, Texas, United States | Recruiting |
| Accurate Clinical Research | Humble, Texas, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07355218